• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  10/19/2009
Trade Name:  Fluarix
Generic or Proper Name (*):  Influenza Virus Vaccine*
Indications Studied:  Active immunization for the prevention of influenza disease caused by virus types A and B contained in the vaccine
Therapeutic Category:  Preventive Vaccine
Ages Studied:  6 months - <18 years
Study #:  1
Study Type:  Safety/Immunogenicity
Study Design:  Single-Blind/Non-inferiority to competitor
No Countries:  1